Lompat ke konten Lompat ke sidebar Lompat ke footer

Widget HTML #1

Orbital Atherectomy Csi

The overall cumulative 3-year MACE rate was 235 including cardiac death 67 MI 112 and TVR 102. CSIs orbital atherectomy technology enables effective calcium modification to facilitate full stent expansion.


Diamondback 360 Coronary Orbital Atherectomy System P130005 Interventional Radiology System Analysis

CSI Diamondback 360 Coronary Orbital Atherectomy System OAS is a catheter-based system designed for facilitating stent.

Orbital atherectomy csi. Orbital Atherectomy OAS Preserves the Media Internal Elastic Lamina IEL Media External Elastic Lamina EEL 1. J of Cardiovasc Trans Res. The plaque ablation catheter consists of a flexible coil-wound drive shaft with an abrasive crown with a diamond-coated surface.

The Diamondback 360 Orbital Atherectomy System OAS Cardiovascular Systems Inc. CSI DIAMONDBACK 360 Coronary Orbital Atherectomy System OAS is a catheter-based system designed for facilitating stent delivery in patients with coronary artery. The Cardiovascular Systems Inc.

CSI Orbital Atherectomy System OAS Saline Infusion Pump Rx only Part Number. The study prospectively evaluated acute clinical outcomes of orbital atherectomy via transradial access for the treatment of peripheral artery disease PAD in lower-extremity lesions using CSIs 5-F extended length Diamondback 360 and Stealth. For use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and stenotic material from artificial arteriovenous dialysis fistulae.

CSI Peripheral Orbital Atherectomy Systems are percutaneous orbital atherectomy systems indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and stenotic material from artificial arteriovenous dialysis fistulae. The ORBIT I trial evaluated the safety and performance of an orbital atherectomy system OAS for the treatment of de novo calcified coronary lesions. For use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and stenotic material from artificial arteriovenous dialysis fistulae.

The plaque ablation catheter the handle and the control console Fig. At Cardiovascular Systems Inc. In addition OAS is optimized for efficiency as it allows bi-directional atherectomy in multiple vessel sizes with one device.

Trial to Study Treatment of Peripheral Artery Disease with Orbital Atherectomy via Radial Access Cardiovascular Systems Inc. System indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and stenotic material from artificial arteriovenous dialysis fistulae. The Systems are contraindicated for use in coronary.

CSIs orbital atherectomy technology enables effective calcium modification to facilitate full stent expansion. Millions of patients with PAD may benefit from treatment with orbital atherectomy utilizing the Stealth 360 and Diamondback 360 Peripheral Orbital Atherectomy Systems minimally invasive catheter systems developed and manufactured by CSI. Adams GL et al.

The pump does not have an indication independent from that of. The ORBIT II trial enrolled 443 subjects to study orbital atherectomy followed by stenting for de novo severely calcified coronary lesions. The CSI Peripheral Orbital Atherectomy System is a percutaneous orbital atherectomy.

The Cardiovascular Systems Inc. The 3-year target lesion revascularization rate. CSI Peripheral Orbital Atherectomy Systems are percutaneous orbital atherectomy systems indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and stenotic material from artificial arteriovenous dialysis fistulae.

CSII a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease announced today that the first patient in Hong Kong has been treated with its Diamondback 360 Coronary Orbital Atherectomy System OAS. CSI our cutting-edge technology and educational courses help physicians understand the challenges that arterial calcium presents and how to intervene with Orbital Atherectomy in appropriate patients with the unified goal of helping improve patient outcomes. CSI Peripheral Orbital Atherectomy System Indications.

This single center prospective randomized study will be conducted to investigate plaque removal and luminal gain using CSIs DIAMONDBACK 360 Peripheral Orbital Atherectomy System OAS StPaul MN versus Medtronics Hawkone Directional Atherectomy system DAS Minneapolis MN assessed by angiography and Intravascular Ultrasound IVUS in patients diagnosed with. The Cardiovascular Systems Inc. Stent placement in calcified lesions can result in stent under expansion malapposition and procedural complications.

Cardiovascular Systems Inc. Paul MN consists of three components. In addition OAS is optimized for efficiency as it allows bi-directional.

CSI Data on file. CSI NASDAQ. Description of the Atherectomy System.

The pump is a component of the OAS that provides the pumping mechanism and power to the OAD. CSI DIAMONDBACK 360 Peripheral Orbital Atherectomy System OAS Exchangeable Series is a minimally invasive catheter-based OAS designed for improving luminal diameter in patients with peripheral arterial disease PAD. Optimal techniques with the Diamondback 360System achieve effective results for the treatment of peripheral arterial disease.

CSI Peripheral Orbital Atherectomy System Indications. CSII a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease announced today the first patient was enrolled in the REACH PVI study. These systems use a diamond-coated crown attached to an orbiting shaft which sands away plaque while preserving healthy vessel tissue a.

CSI is leading the way with their peripheral orbital atherectomy device as its the only atherectomy system available that is designed to treat through the radial artery Scott Ward CSI Chairman President and Chief Executive Officer said The positive data from REACH PVI confirms our belief that our low-profile OAS is uniquely positioned to safely treat patients suffering from PAD. Severely calcified coronary arteries pose an ongoing treatment challenge.


Csi360 Cardiovascular System New Directions Cardiovascular


Outback Re Entry Catheter Johnson Johnson Interventional Radiology Johnson And Johnson Catheter


Pin On Intervenional Radiology


Posting Komentar untuk "Orbital Atherectomy Csi"

https://www.highrevenuegate.com/zphvebbzh?key=b3be47ef4c8f10836b76435c09e7184f